Perelman School of Medicine Professor of Oncology and a member of the Advisory Group of the Penn Center for Cancer Care Innovation (PC3I) Susan Domchek, MD, is featured in an article in Cancer Today about women who are not getting screened for BRCA1 or BRCA2 mutations that increase the risk of various cancers.
The article points out that 25 years after the mutations were discovered, the guidelines for who should be tested have changed a number of times. And it’s now known that the same gene mutations can increase the risk of cancer in men.
At least 1.2 million women who meet the criteria to be tested for the genes, have not been tested, the magazine reports. In her interview, Domchek points out that “it’s important to remember that there are a lot of people at the highest risk for having these mutations who are not getting access to testing… and this is often minorities. So, we need to address this disparity.”
Cancer Today is a publication of the American Association for Cancer Research that circulates to cancer patients, survivors and caregivers throughout the U.S.
Reflecting on 50 years of the National Cancer Act, PC3I Faculty Ravi Parikh shares his thoughts with AARP on new cancer treatments and improvements in managing treatment side effects.
Dr. Christine Edmonds and PC3I Faculty Dr. Lola Fayanju share several ways in which Black women experience socioeconomic barriers and systemic biases that impact breast cancer treatment and survival.
Researchers from the Population-based Research to Optimize the Screening Process (PROSPR) Consortium are working to eliminate disparities in uptake of lung cancer screening.